Early research (Phase 1)Ended earlyNCT03996473
What this trial is testing
Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases
Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bayer 8